medium
Sell
4,591 shares
$1,151,774
Significance
4/10
Director John L Lamattina sold 4,591 shares of LGND for $1,151,774.29 across 4 transactions on 2026-06-10
John L Lamattina, a Director at Ligand Pharmaceuticals, executed 4 separate sales totaling 4,591 shares for $1,151,774.29 on 2026-06-10, reducing his holdings from 31,560 shares to 26,969 shares (a 14.5% reduction in stake). The stock has appreciated 15.5% over the past 30 days and 25.9% over 90 days, and currently trades at $255.54, marginally below its 52-week high of $259.03. Ligand reported a latest-quarter net loss of $-13,345,000.00 despite annual revenue growth of 60.4% year-over-year, reflecting operational challenges despite strong top-line expansion.